At TrimRx, we hear from many people who wonder if a simple change in their routinelike where they choose to pokecould make the difference between feeling great and feeling sidelined
Figure 3: Emerging indications and research frontiers for GLP-1s Neurodegenerative diseases One of the most closely watched areas is GLP-1s potential in treating neurodegenerative diseases
Xinhua Qu, [email protected] Specialty section: This article was submitted to Bone Research, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
This genetic complexity of human diseases limits the broad application of gene editing therapies, except for well-known diseases caused by mutations of a single gene, like sickle cell anemia 14
However, non-diabetic patients do not face the hypoglycemia risk that diabetics encounter, meaning they can use these medications without the same blood sugar monitoring requirements
Hikma: settling the skinny label question Labiotech.eu, accessed February 2, 2026, SPCs in Europe: whats round the corner